BridgeMD
New treatment option for Analgesic Drugs
Official title Continuous vs. Bolus Administration of NSAIDs After Laparoscopic Surgery for Multimodal Analgesia
ClinicalTrials.gov ID: NCT07070050
What this study is testing
What is Ibuprofen continuous infusion?
Ibuprofen continuous infusion is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for analgesic drugs.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Currently the prevalent approach to perioperative management of patients is ERAS (Enhanced Recovery After Surgery) concept. This approach includes numerous aspects, among which the perioperative use of multimodal analgesia takes one of the leading places.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age \> 18 years old
- Elective laparoscopic surgery
- General anesthesia
- Signed informed consent from the patient to participate in the study
- RASS scale from -2 to +1 on admission to a surgical department or ICU
You likely can't join if
- History of ibuprofen allergy
- Active erosive or ulcerative lesions of the gastrointestinal tract
- Chronic use of opioid analgesics or NSAIDs prior to enrollment
- Chronic kidney disease ≥ 3b stage according to the KDIGO classification
- Liver dysfunction (three times exceeding the upper reference limit of ALT or AST)
- A history of bronchial asthma
See the full eligibility criteria
- Age \> 18 years old
- Elective laparoscopic surgery
- General anesthesia
- Signed informed consent from the patient to participate in the study
- RASS scale from -2 to +1 on admission to a surgical department or ICU
- History of ibuprofen allergy
- Active erosive or ulcerative lesions of the gastrointestinal tract
- Chronic use of opioid analgesics or NSAIDs prior to enrollment
- Chronic kidney disease ≥ 3b stage according to the KDIGO classification
- Liver dysfunction (three times exceeding the upper reference limit of ALT or AST)
- A history of bronchial asthma
- A history of hereditary coagulopathies
- A history of use of anticoagulants
The study team makes the final eligibility decision.
Where it's taking place
- Moscow, Moscow Oblast, Russia
Compensation & support
Compensation likely.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Moscow, Moscow Oblast, Russia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.